Cefprozil NDC 68180-403

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-403Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0403Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68180-403-01	68180040301	100 TABLET in 1 BOTTLE (68180-403-01)Marketed from Dec 1, 2005

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefprozil
Generic name (nonproprietary): cefprozil
Active ingredients: Cefprozil — 250 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065276
Marketing start: Dec 1, 2005
Listing expires: Dec 31, 2026
Identifiers: Product ID 68180-403_b5bc3f77-ca01-4c3f-b8b6-591a3d8f73f4SPL ID b5bc3f77-ca01-4c3f-b8b6-591a3d8f73f4SPL set ID 14527f4a-ce99-449d-a5a5-9edd7fb28deeRxCUI 197452, 197453UNII 4W0459ZA4V

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468180040301 followed by a unit qualifier and the quantity

Package 68180-0403-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 10, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Upper Respiratory Tract: Pharyngitis/Tonsillitis: Caused by Streptococcus pyogenes . NOTE: The usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. Cefprozil is generally effective in the eradication of Streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065276

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065276
Product	Strength	Form · route	Labeler	Product NDC
Cefprozil	Cefprozil 500 mg/1	TabletOral	Lupin Pharmaceuticals, Inc.	68180-404